🇺🇸 FDA
Patent

US 9382230

Methods and compositions for modulating Ire1, SRC and ABL activity

granted A61KA61K31/4155A61K31/497

Quick answer

US patent 9382230 (Methods and compositions for modulating Ire1, SRC and ABL activity) held by The Regents of the University of California expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4155, A61K31/497, A61P, A61P21/00